Approvals/TGA/HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL vial

Approved

STANDARD

HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a662407b0996a18a
Product Name: HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL vial
Artg Id: 207384
Artg Name: HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2014-05-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01242-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-03180-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

a662407b0996a18a

Type

Standard